President Donald Trump suggested Tuesday his administration intends to impose a 200% tariff rate on pharmaceutical imports ...

CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

President Donald Trump said Tuesday he’s imposing a new 50% tariff on all copper. However, it’s unclear when the new tariff ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

Trump has rolled back many of his steepest tariffs over recent months, including a sky-high levy on China, the top source of U.S. imports. In recent days, however, Trump announced plans to slap ...

While the bilateral trade negotiations are in the final stages of discussion between India and the US, the tariffs announced ...

Trump suggested that those levies would not go into effect immediately, saying he will “give people about a year, year and a half” ...

The US is Australia’s biggest export market for pharmaceuticals. If the tariffs go ahead, manufacturing could suffer.

President Trump announced his intent to impose tariffs on imported pharmaceuticals and semiconductors, which may reach 200%.